FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073296427> ?p ?o ?g. }

• W2073296427 endingPage "93" @default.
• W2073296427 startingPage "87" @default.
• W2073296427 abstract "The purpose of this study was to determine the frequency of BCL2, BCL6, IGH, TP53, and MYC protein expression and rearrangements of the respective genes in diffuse large B-cell lymphoma (DLBCL) patients and to assess their prognostic values. Samples from 44 patients with DLBCL were evaluated using fluorescence in situ hybridization and immunohistochemical analyses. BCL6 was the most rearranged gene (63.6%), followed by MYC (31.8%), TP53 (22.7%), and BCL2 (18.2%). Multiple rearrangements were detected in 40.9% of the cases. BCL6 was the most expressed protein (78.6%), followed by TP53 (69.04%), BCL2 (59.5%) and MYC (14.3%). Expression of multiple proteins was detected in 67.4% of the cases. BCL2 (P = .003) expression had a significant negative influence on overall survival,whereas BCL6 (P = .014) expression had a significant positive influence. Our results with a different pattern of gene rearrangements and associated protein overexpression indicate the molecular genetic complexity of DLBCLs, which reflects the morphologic, biologic, and clinical heterogeneity of these lymphomas. The purpose of this study was to determine the frequency of BCL2, BCL6, IGH, TP53, and MYC protein expression and rearrangements of the respective genes in diffuse large B-cell lymphoma (DLBCL) patients and to assess their prognostic values. Samples from 44 patients with DLBCL were evaluated using fluorescence in situ hybridization and immunohistochemical analyses. BCL6 was the most rearranged gene (63.6%), followed by MYC (31.8%), TP53 (22.7%), and BCL2 (18.2%). Multiple rearrangements were detected in 40.9% of the cases. BCL6 was the most expressed protein (78.6%), followed by TP53 (69.04%), BCL2 (59.5%) and MYC (14.3%). Expression of multiple proteins was detected in 67.4% of the cases. BCL2 (P = .003) expression had a significant negative influence on overall survival,whereas BCL6 (P = .014) expression had a significant positive influence. Our results with a different pattern of gene rearrangements and associated protein overexpression indicate the molecular genetic complexity of DLBCLs, which reflects the morphologic, biologic, and clinical heterogeneity of these lymphomas." @default.
• W2073296427 created "2016-06-24" @default.
• W2073296427 creator A5006123216 @default.
• W2073296427 creator A5010828709 @default.
• W2073296427 creator A5031256616 @default.
• W2073296427 creator A5032274461 @default.
• W2073296427 creator A5058571002 @default.
• W2073296427 creator A5064303361 @default.
• W2073296427 creator A5064350163 @default.
• W2073296427 creator A5067568753 @default.
• W2073296427 date "2014-03-01" @default.
• W2073296427 modified "2023-09-26" @default.
• W2073296427 title "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients" @default.
• W2073296427 cites W151022074 @default.
• W2073296427 cites W1853245606 @default.
• W2073296427 cites W1952207705 @default.
• W2073296427 cites W1965527127 @default.
• W2073296427 cites W1983020016 @default.
• W2073296427 cites W1985807829 @default.
• W2073296427 cites W2001923666 @default.
• W2073296427 cites W2014610542 @default.
• W2073296427 cites W2024817084 @default.
• W2073296427 cites W2026214119 @default.
• W2073296427 cites W2028096444 @default.
• W2073296427 cites W2029823192 @default.
• W2073296427 cites W2037796411 @default.
• W2073296427 cites W2047565785 @default.
• W2073296427 cites W205637700 @default.
• W2073296427 cites W2057239580 @default.
• W2073296427 cites W2068164920 @default.
• W2073296427 cites W2075696892 @default.
• W2073296427 cites W2077832231 @default.
• W2073296427 cites W2100111427 @default.
• W2073296427 cites W2100197564 @default.
• W2073296427 cites W2115661984 @default.
• W2073296427 cites W2116477075 @default.
• W2073296427 cites W2120415962 @default.
• W2073296427 cites W2124872952 @default.
• W2073296427 cites W2129730789 @default.
• W2073296427 cites W2133131759 @default.
• W2073296427 cites W2133391023 @default.
• W2073296427 cites W2137216850 @default.
• W2073296427 cites W2139204503 @default.
• W2073296427 cites W2139211474 @default.
• W2073296427 cites W2150560566 @default.
• W2073296427 cites W2157883906 @default.
• W2073296427 cites W2159862107 @default.
• W2073296427 cites W2168438686 @default.
• W2073296427 cites W2170315615 @default.
• W2073296427 cites W2299804566 @default.
• W2073296427 cites W3112177578 @default.
• W2073296427 cites W41459023 @default.
• W2073296427 doi "https://doi.org/10.1016/j.cancergen.2014.02.001" @default.
• W2073296427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24674866" @default.
• W2073296427 hasPublicationYear "2014" @default.
• W2073296427 type Work @default.
• W2073296427 sameAs 2073296427 @default.
• W2073296427 citedByCount "16" @default.
• W2073296427 countsByYear W20732964272014 @default.
• W2073296427 countsByYear W20732964272015 @default.
• W2073296427 countsByYear W20732964272016 @default.
• W2073296427 countsByYear W20732964272017 @default.
• W2073296427 countsByYear W20732964272018 @default.
• W2073296427 countsByYear W20732964272019 @default.
• W2073296427 countsByYear W20732964272020 @default.
• W2073296427 countsByYear W20732964272021 @default.
• W2073296427 crossrefType "journal-article" @default.
• W2073296427 hasAuthorship W2073296427A5006123216 @default.
• W2073296427 hasAuthorship W2073296427A5010828709 @default.
• W2073296427 hasAuthorship W2073296427A5031256616 @default.
• W2073296427 hasAuthorship W2073296427A5032274461 @default.
• W2073296427 hasAuthorship W2073296427A5058571002 @default.
• W2073296427 hasAuthorship W2073296427A5064303361 @default.
• W2073296427 hasAuthorship W2073296427A5064350163 @default.
• W2073296427 hasAuthorship W2073296427A5067568753 @default.
• W2073296427 hasConcept C104317684 @default.
• W2073296427 hasConcept C142724271 @default.
• W2073296427 hasConcept C150194340 @default.
• W2073296427 hasConcept C153911025 @default.
• W2073296427 hasConcept C159654299 @default.
• W2073296427 hasConcept C203014093 @default.
• W2073296427 hasConcept C204232928 @default.
• W2073296427 hasConcept C2777537477 @default.
• W2073296427 hasConcept C2777542201 @default.
• W2073296427 hasConcept C2778453870 @default.
• W2073296427 hasConcept C2778559949 @default.
• W2073296427 hasConcept C2779338263 @default.
• W2073296427 hasConcept C30481170 @default.
• W2073296427 hasConcept C502942594 @default.
• W2073296427 hasConcept C54355233 @default.
• W2073296427 hasConcept C71924100 @default.
• W2073296427 hasConcept C81439078 @default.
• W2073296427 hasConcept C86803240 @default.
• W2073296427 hasConcept C96926380 @default.
• W2073296427 hasConceptScore W2073296427C104317684 @default.
• W2073296427 hasConceptScore W2073296427C142724271 @default.
• W2073296427 hasConceptScore W2073296427C150194340 @default.
• W2073296427 hasConceptScore W2073296427C153911025 @default.

• next